HMGA2 Moderately Increases Fetal Hemoglobin Expression in Human Adult Erythroblasts

Area of Science:

• Molecular Biology
• Hematology
• Gene Regulation

Background:

• Fetal hemoglobin (HbF) induction is crucial for treating beta-hemoglobin disorders.
• let-7 microRNAs (miRNAs) regulate erythroid cell development and HbF levels.
• HMGA2 is a validated target of let-7 miRNAs and its role in HbF regulation is explored.

Purpose of the Study:

• To investigate if HMGA2 expression directly regulates fetal hemoglobin in adult erythroblasts.
• To assess the impact of HMGA2 overexpression on gamma-globin gene and protein expression.

Main Methods:

• Lentiviral transduction of CD34(+) cells with let-7 resistant HMGA2.
• Expression of HMGA2 regulated by the erythroid-specific SPTA1 gene promoter (HMGA2-OE).
• Quantification of gamma-globin mRNA and HbF levels in transduced erythroblasts.

Main Results:

• HMGA2 overexpression (HMGA2-OE) led to significant increases in gamma-globin mRNA and HbF levels (approx. 16% of total hemoglobin).
• No significant changes were observed in the mRNA levels of key erythroid transcription factors (KLF1, SOX6, GATA1, ZBTB7A, BCL11A).
• HMGA2-OE demonstrated a moderate but significant induction of HbF in adult human erythroblasts.

Conclusions:

• HMGA2 expression directly contributes to increased gamma-globin gene and protein expression in adult human erythroblasts.
• Targeting HMGA2 offers a potential therapeutic strategy for increasing HbF in beta-hemoglobinopathies.
• HMGA2 acts downstream of let-7 miRNAs in the regulation of fetal hemoglobin production.